Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
. 1998 May;77(9):1514–1518. doi: 10.1038/bjc.1998.249

Survival analysis of 5595 head and neck cancers--results of conventional treatment in a high-risk population.

D N Rao 1, P D Shroff 1, G Chattopadhyay 1, K A Dinshaw 1
PMCID: PMC2150195  PMID: 9652771

Abstract

This is a study of 5595 head and neck cancer patients treated during 1987-89 at TMH, Mumbai. The study included 1970 oral cancers (ICD 140-145), 1495 oropharyngeal cancers (ICD 1410, 1453, 146), 1255 hypopharyngeal cancers (ICD 148), 125 nasopharyngeal cancers (ICD 147) and 750 laryngeal cancers (ICD 161). The clinical extent of disease at presentation was based on TNM group staging (UICC 1978). For the majority of sites, patients attended the hospital during stage III and stage IV of the disease; the only exception was for cancers of the lower lip, anterior tongue and vocal cord when between 46.2% and 56.5% of patients with localized cancer (stage I and II) were seen. Generally, surgery either alone or with radiation has been administered for oral cancer patients whereas radiation either alone or in combination with chemotherapy was administered for other head and neck sites. The overall 5-year survival rate was in the range of 20-43% for oral cancer, 8-25% for pharyngeal cancers and 25-62% for laryngeal cancer. The 5-year relative survival rates were more or less in agreement with the results published by the Eurocare study for head and neck cancers. The importance of primary prevention in head and neck cancer is stressed.

Full text

PDF
1514

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cole D. A., Patel P. M., Matar J. R., Kenady D. E., Maruyama Y. Floor of the mouth cancer. Arch Otolaryngol Head Neck Surg. 1994 Mar;120(3):260–263. doi: 10.1001/archotol.1994.01880270008002. [DOI] [PubMed] [Google Scholar]
  2. Flores A. D., Dickson R. I., Riding K., Coy P. Cancer of the nasopharynx in British Columbia. Am J Clin Oncol. 1986 Aug;9(4):281–291. doi: 10.1097/00000421-198608000-00002. [DOI] [PubMed] [Google Scholar]
  3. Grau J. J., Cuchi A., Traserra J., Fírvida J. L., Arias C., Blanch J. L., Estapé J. Follow-up study in head and neck cancer: cure rate according to tumor location and stage. Oncology. 1997 Jan-Feb;54(1):38–42. doi: 10.1159/000227659. [DOI] [PubMed] [Google Scholar]
  4. Mishra R. C., Singh D. N., Mishra T. K. Post-operative radiotherapy in carcinoma of buccal mucosa, a prospective randomized trial. Eur J Surg Oncol. 1996 Oct;22(5):502–504. doi: 10.1016/s0748-7983(96)92969-8. [DOI] [PubMed] [Google Scholar]
  5. Mohanti B. K., Tandon D. A., Bahadur S., Rath G. K., Tanwar R. K., Lal P., Biswal B. M. Results of definitive radiotherapy in T1 and T2 glottic carcinoma: Institute of Rotary Cancer Hospital experience. Australas Radiol. 1996 Aug;40(3):287–290. doi: 10.1111/j.1440-1673.1996.tb00405.x. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES